Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epidemiology of cholangiocarcinoma
Maria Qurashi, Mathew Vithayathil, Shahid A. Khan
European Journal of Surgical Oncology (2023), pp. 107064-107064
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Mapping the landscape of biliary tract cancer in Europe: challenges and controversies
Lorenza Rimassa, Shahid A. Khan, Bas Groot Koerkamp, et al.
The Lancet Regional Health - Europe (2025) Vol. 50, pp. 101171-101171
Open Access | Times Cited: 1
Cholangiocarcinoma: The Current Status of Surgical Options including Liver Transplantation
Abdullah Esmail, Mohamed Badheeb, Batool Wael Alnahar, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 1946-1946
Open Access | Times Cited: 6
Prognostic Impact of Visceral Adipose Tissue Imaging Parameters in Patients with Cholangiocarcinoma after Surgical Resection
Jeong Won Lee, Ik Dong Yoo, Sun-pyo Hong, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3939-3939
Open Access | Times Cited: 4
Biliary tract cancer
Kjetil Søreide, Cristina Dopazo, Frederik Berrevoet, et al.
European Journal of Surgical Oncology (2024), pp. 108489-108489
Open Access | Times Cited: 4
ADAMDEC1 promotes the malignant progression of cholangiocarcinoma by regulating NF-κB signaling pathway
Shuo Zhou, Yuhang Yang, Feiyu Qi, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Prognostic Significance of Lymph Node Ratio in Intrahepatic and Extrahepatic Cholangiocarcinomas
Andrii Khomiak, Sumaya Abdul Ghaffar, Salvador Rodriguez Franco, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 220-220
Open Access
Prognostic factors for survival in patients with advanced cholangiocarcinoma treated with percutaneous transhepatic drainage
Tomáš Rohan, Barbora Čechová, Peter Matkulčík, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Preoperative Blood and CT-Image Nutritional Indicators in Short-Term Outcomes and Machine Learning Survival Framework of Intrahepatic Cholangiocarcinoma
Mingxun Wang, Xiaozai Xie, Jiacheng Lin, et al.
European Journal of Surgical Oncology (2025), pp. 109654-109654
Closed Access
Advancements in Locoregional Therapies for Unresectable Intrahepatic Cholangiocarcinoma
C. O'Donnell, Umair Majeed, Michael Rutenberg, et al.
Current Oncology (2025) Vol. 32, Iss. 2, pp. 82-82
Open Access
EZH2‐Mediated PHF10 Suppression Amplifies HMGB1/NF‐κB Axis That Confers Chemotherapy Resistance in Cholangiocarcinoma
Qiushi Yin, Dingsheng Lin, Weiqian Zeng, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 3
Open Access
A Case of Biliary Intraepithelial Neoplasm in a Young Man Diagnosed by Laparoscopic Hepatectomy to Treat Recurrent Intrahepatic Lithiasis and Cholangitis
Yuto Yamahata, Jungo Yasuda, Hironori Shiozaki, et al.
Surgical Case Reports (2025) Vol. 11, Iss. 1, pp. n/a-n/a
Open Access
Causality of blood metabolites on hepatocellular carcinoma and cholangiocarcinoma: a metabolome-wide mendelian randomization study
Lin Ning, Zhanhua Gao, Di Chen, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Highly Accurate and Robust Early Stage Detection of Cholangiocarcinoma Using Near-Lossless SERS Signal Processing with Machine Learning and 2D CNN for Point-of-care Mobile Application
Pobporn Danvirutai, Thatsanapong Pongking, Suppakrit Kongsintaweesuk, et al.
ACS Omega (2025)
Open Access
Polypharmacology: new drugs in 2023–2024
Piotr Ryszkiewicz, Barbara Malinowska, Eberhard Schlicker
Pharmacological Reports (2025)
Open Access
CLDN18.2: a potential nanotherapeutic target for cholangiocarcinoma
Yu Huang, Yulu Ye, Tingzhuang Yi, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Targeted Therapies in Advanced Cholangiocarcinoma
Michael H. Storandt, Peter C. Kurniali, Amit Mahipal, et al.
Life (2023) Vol. 13, Iss. 10, pp. 2066-2066
Open Access | Times Cited: 7
Management and mechanism of calciphylaxis in a patient treated with the FGFR inhibitor pemigatinib—a case report
Sreenivasa R Chandana, Austin Frisch, Sergio Mendoza, et al.
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 1, pp. 478-484
Open Access | Times Cited: 2
Current interventional options for palliative care for patients with advanced-stage cholangiocarcinoma
Maryam Makki, Malak Bentaleb, Mohammed Abdulrahman, et al.
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 3, pp. 381-390
Open Access | Times Cited: 2
RBM10 C761Y mutation induced oncogenic ASPM isoforms and regulated β-catenin signaling in cholangiocarcinoma
Jiang Chang, Yaodong Zhang, Tao Zhou, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
Nomogram for Predicting Survival Post-Immune Therapy in Cholangiocarcinoma Based on Inflammatory Biomarkers
Jianan Jin, Haibo Mou, Yibin Zhou, et al.
Cancer Control (2024) Vol. 31
Open Access | Times Cited: 2
Survival After Transarterial Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: An Updated Meta-analysis and Meta-regression
Maria Adriana Cocozza, Elton Dajti, Lorenzo Braccischi, et al.
CardioVascular and Interventional Radiology (2024) Vol. 47, Iss. 10, pp. 1313-1324
Open Access | Times Cited: 1
Biologic activity and treatment resistance to gastrointestinal cancer: the role of circular RNA in autophagy regulation
Bo Zhang, Zhe Li, Guoliang Ye, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Polysaccharide extract of Spirulina sp. increases effector immune-cell killing activities against cholangiocarcinoma
Aussara Panya, Methi Wathikthinnakon, Chutamas Thepmalee, et al.
PLoS ONE (2024) Vol. 19, Iss. 10, pp. e0312414-e0312414
Open Access | Times Cited: 1
The morphomolecular features of cholangiocarcinoma in the personalised era
Daniel T. Field, Guido Carpino, Michail Doukas, et al.
Diagnostic histopathology (2024) Vol. 30, Iss. 4, pp. 237-251
Open Access
Intraductal magnetic resonance imaging of cholangiocarcinoma - a practical possibility
R.R.A. Syms, Christopher A. Wadsworth, Evdokia M. Kardoulaki, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Page 1 - Next Page

Scroll to top